The prospect of health industry is broad, the transformation of pharmaceutical enterprises flows into the direct marketing industry

[market analysis of China Pharmaceutical network] with the increasing demand, the market potential of health products is growing It is estimated that in 2017, the output value of nutrition and health food will exceed 1 trillion yuan, with an average annual growth of 20% According to some data, it is expected that the health care product market in China will grow at an annual rate of 11% in the future, and the whole market scale is expected to exceed 400 billion yuan by 2020 On May 24, the Ministry of Commerce announced that Beijing Tongrentang has been licensed So far, 34 licensed direct selling pharmaceutical enterprises have reached, accounting for 1 / 3 of the total number of licensed direct selling enterprises The entry of pharmaceutical enterprises into direct selling once again attracted the attention of the industry In recent years, more and more pharmaceutical companies have successfully applied for direct selling license plates with the acceleration of the licensing speed of the Ministry of Commerce More and more pharmaceutical companies began to enter the field of direct marketing in 2016 At the executive meeting of the State Council, five measures were determined to promote the development of traditional Chinese medicine, and the pharmaceutical industry began to attract attention from all walks of life This makes a lot of pharmaceutical enterprises, especially some pharmaceutical enterprises which mainly use traditional Chinese medicine ingredients as raw materials, see the hope At the same time, with people from all walks of life optimistic about the direct marketing industry, many pharmaceutical enterprises began to focus on the direct marketing industry In fact, as early as 2013, pharmaceutical companies have been accompanied by direct sales At the end of 2013, three pharmaceutical enterprises under ideal technology, Kangmei pharmaceutical and Jiuji biology under Xiangxue pharmaceutical obtained the direct marketing license issued by the Ministry of Commerce In addition to the previous four pharmaceutical enterprises, Kingsley Jiayou, Guangdong Kangli, Harbin Pharmaceutical Group and Xiamen Jinri, seven pharmaceutical enterprises have been involved in direct marketing In 2014, the team of "pharmaceutical enterprises + direct marketing" business model grew continuously, and the statement of applying for direct marketing license showed that the number of pharmaceutical enterprises that wanted to enter and share the direct marketing industry increased gradually At the beginning of 2015, the enterprises such as dong'a-jiao and Weikang biology have obtained the direct marketing license issued by the Ministry of Commerce Last year, the number of pharmaceutical enterprises with the license has reached a staggering 7 Recently, the management information system of the direct selling industry of the Ministry of Commerce announced the list of 22 enterprises that have been accepted for licensing Pharmaceutical enterprises continue to flow into the direct marketing of 22 public enterprises, 7 of which are pharmaceutical enterprises or related to the pharmaceutical industry They are Shandong Fuda, Weihai KangBo pharmaceutical, amendment group, Shandong Yiyang Liquor Group (Yiyang pharmaceutical), Jiangxi Dadi pharmaceutical, Shenwei Pharmaceutical Co., Ltd and Jiangsu Kangyuan group In the era of transformation of pharmaceutical industry and outbreak of big health industry, in recent years, the pace of traditional pharmaceutical enterprises entering into direct marketing has not stopped, but also intensified From the results of this publicity, traditional pharmaceutical companies are still in the ferment of entering direct marketing These pharmaceutical enterprises with strong scientific research, production and product strength will flow into direct marketing, which will surely bring more new products and new health concepts to consumers in the future It is understood that most of the direct marketing products of pharmaceutical enterprises are cosmetics and health products, such as the direct marketing products of yongchuntang are cosmetics, health food and daily necessities; the direct marketing products of dong'a-jiao and Weikang are only health food; the direct marketing products of Freida are cosmetics and health food Although the main industry of pharmaceutical enterprises is pharmaceutical products, which do not belong to the five categories of direct sales products, large pharmaceutical enterprises have strong production technology and R & D strength These technical advantages are enough to support the development of health food, cosmetics, cleaning products and other products, and use this advantage to continuously launch new products suitable for consumers' needs Products will bring new opportunities to the development of pharmaceutical direct selling enterprises Health industry has broad market prospect Due to the demand of Chinese consumers for health care products, the market potential of health care products is huge It is estimated that in 2017, the output value of nutrition and health care products will exceed 1 trillion yuan, with an average annual growth of 20% According to some data, it is estimated that the market of health care products in China will grow at an annual growth rate of 11%, and the whole market scale is expected to exceed 400 billion yuan by 2020 Judging from the development and trend in 2016, the direct selling industry is bound to be a year of explosion in 2017, so more enterprises will join in the team of licensing application In 2016, the state will pay more attention and love to pharmaceutical enterprises, especially those with traditional Chinese medicine as raw materials, which will undoubtedly be a very good opportunity for pharmaceutical enterprises With the development and expansion of the health industry, it is not only a job for me to engage in direct selling health industry for you From the perspective of the general environment, the health industry will be a sunrise industry in the next ten or twenty years, with many investment opportunities, and direct selling is a good choice Original title: pharmaceutical enterprises continue to flow into direct sales, health industry market ushered in great development!